The NHI is designed to advance South Africa’s progress toward Universal Health Coverage by ensuring equitable access to ...

The U.S. and Eswatini have entered a five-year health cooperation agreement involving a $242 million understanding to enhance ...

The Trump administration is continuing its global health plan to provide aid while requiring investment from the country ...

Guyana intends to purchase lenacapavir, an anti-retroviral that scientists say can offer protection against Human Immuno-deficiency Virus (HIV) that causes Acquired Immune Deficiency Syndrome ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

Lenacapavir is one of the latest HIV-prevention drugs that health experts are looking to, in the effort to end the HIV epidemic. Reporter Leah Kahunde Ndung’u examines what Lenacapavir’s rollout could ...

Accra, Dec 8, GNA – The Society for AIDS in Africa (SAA) has marked its 35th anniversary on the sidelines of the ongoing International Conference on AIDS and Sexually Transmitted Infections in Africa ...

This week across Africa, health warnings are mounting due to several intersecting factors. We are seeing a sharp rise in malaria cases continent-wide, which is further exacerbated by persistent ...

Malawi on Thursday, December 4, authorised the use of the injectable HIV prevention drug lenacapavir, becoming the fourth ...

Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the ...

On World AIDS Day, the World Health Organisation (WHO) called on governments and global health partners to urgently scale up access to newly approved HIV prevention tools—especially the long-acting ...